tiprankstipranks
Trending News
More News >

Sinopharm Group Announces Share Repurchase Mandate

Story Highlights
Sinopharm Group Announces Share Repurchase Mandate

Don’t Miss TipRanks’ Half-Year Sale

Sinopharm Group Co ( (HK:1099) ) has shared an announcement.

Sinopharm Group Co. Ltd. has announced a special resolution for a shareholders’ class meeting to grant the Board a mandate to repurchase up to 10% of its H Shares. This move is aimed at enhancing capital management flexibility and potentially stabilizing the company’s share price, reflecting a strategic decision to optimize shareholder value.

The most recent analyst rating on (HK:1099) stock is a Buy with a HK$29.30 price target. To see the full list of analyst forecasts on Sinopharm Group Co stock, see the HK:1099 Stock Forecast page.

More about Sinopharm Group Co

Sinopharm Group Co. Ltd. is a leading pharmaceutical company in China, primarily engaged in the distribution of pharmaceutical and healthcare products. It operates in the healthcare industry with a focus on the Chinese market, providing a wide range of medical supplies and services.

Average Trading Volume: 7,707,441

Technical Sentiment Signal: Sell

Current Market Cap: HK$57.82B

For a thorough assessment of 1099 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1